We are live on
!
Find out more
CPA
Capital Planning Advisors Portfolio holdings
AUM
$692M
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.81%
1 Year Est. Return
+21.81%
3 Year Est. Return
+64.23%
5 Year Est. Return
+70.81%
10 Year Est. Return
+288.35%
AUM
$282M
AUM Growth
-$2.99M
(-1%)
Cap. Flow
+$904K
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
41.03%
Holding
126
New
6
Increased
52
Reduced
47
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$3.52M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$3.31M |
| 3 |
SLB Ltd
SLB
|
+$1.04M |
| 4 |
Goldman Sachs
GS
|
+$790K |
| 5 |
Ross Stores
ROST
|
+$578K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$2.96M |
| 2 |
Philip Morris
PM
|
+$1.14M |
| 3 |
Eli Lilly
LLY
|
+$1.13M |
| 4 |
Vanguard Value ETF
VTV
|
+$908K |
| 5 |
Hasbro
HAS
|
+$818K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Industrials | 10.19% |
| 3 | Financials | 8.51% |
| 4 | Healthcare | 7.41% |
| 5 | Communication Services | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Target
TGT
$66.6B
| $405K | 0.14% |
+5,838
| New | +$425K |
|
102
Progressive
PGR
$128B
| $372K | 0.13% |
6,103
| – | – |
|
|
UMPQ
103
DELISTED
Umpqua Holdings Corp
UMPQ
| $368K | 0.13% |
17,165
-10,000
| -37% | -$218K |
|
104
Norfolk Southern
NSC
$75.4B
| $356K | 0.13% |
2,622
-8
| -0.3% | -$1.15K |
|
105
IBM
IBM
$216B
| $334K | 0.12% |
+2,278
| New | +$345K |
|
106
Clorox
CLX
$12B
| $313K | 0.11% |
2,350
-350
| -13% | -$47K |
|
107
FS KKR Capital
FSK
$3.04B
| $304K | 0.11% |
10,483
| – | – |
|
|
KLDW
108
DELISTED
Knowledge Leaders Developed World ETF
KLDW
| $283K | 0.1% |
8,276
+177
| +2% | +$6.07K |
|
109
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
| $276K | 0.1% |
3,390
| – | – |
|
110
Emerson Electric
EMR
$82.8B
| $268K | 0.1% |
3,920
| – | – |
|
111
Applied Materials
AMAT
$362B
| $262K | 0.09% |
4,716
+24
| +0.5% | +$1.34K |
|
112
Duke Energy
DUK
$101B
| $259K | 0.09% |
3,349
-218
| -6% | -$16.9K |
|
113
Medtronic
MDT
$112B
| $246K | 0.09% |
3,066
| – | – |
|
114
Paycom
PAYC
$7.98B
| $215K | 0.08% |
+2,001
| New | +$192K |
|
115
Micron Technology
MU
$876B
| $213K | 0.08% |
+4,080
| New | +$195K |
|
116
Vanguard Total Stock Market ETF
VTI
$654B
| $206K | 0.07% |
1,521
-69
| -4% | -$9.68K |
|
|
MBII
117
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $66K | 0.02% |
33,079
+21,579
| +188% | +$28.9K |
|
118
Allstate
ALL
$70.3B
| – | – |
-2,156
| Closed | -$226K |
|
119
iShares MSCI EAFE ETF
EFA
$76.9B
| – | – |
-5,420
| Closed | -$381K |
|
120
Enbridge
ENB
$121B
| – | – |
-5,564
| Closed | -$218K |
|
121
GE Aerospace
GE
$368B
| – | – |
-2,195
| Closed | -$184K |
|
|
122
Hasbro
HAS
$13.5B
| – | – |
-9,004
| Closed | -$818K |
|
|
123
iShares Biotechnology ETF
IBB
$9.51B
| – | – |
-27,709
| Closed | -$2.96M |
|
|
124
Eli Lilly
LLY
$1.09T
| – | – |
-13,363
| Closed | -$1.13M |
|
125
Merck
MRK
$324B
| – | – |
-4,003
| Closed | -$215K |
|
Similar funds
CL
NMC
SSA
WC
WIM
LCP
SAM
ACM
Capital Planning Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Capital Planning Advisors held 126 positions worth $282M, down 1% from $285M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Capital Planning Advisors's Q1 2018 filing shows 6 new, 52 increased, 47 reduced and 9 closed positions. Its largest new stake was State Street Consumer Discretionary Select Sector SPDR ETF: 63,488 shares worth $3.21M. The largest sale was iShares Biotechnology ETF, an estimated $2.96M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Financials.
- Capital Planning Advisors's largest Q1 2018 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 63,488 shares worth $3.21M.
- Capital Planning Advisors added most to Vanguard FTSE All-World ex-US ETF in Q1 2018, an estimated $3.52M increase.
- Capital Planning Advisors's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $1.14M.
- Capital Planning Advisors fully exited iShares Biotechnology ETF in Q1 2018, selling an estimated $2.96M.
- Capital Planning Advisors's ten largest holdings make up 41% of its $282M portfolio in Q1 2018.
- Capital Planning Advisors opened 6 new positions and closed 9 in Q1 2018.
- Capital Planning Advisors's portfolio value fell 1% quarter-over-quarter to $282M.
Based on Capital Planning Advisors's 13F filing for Q1 2018, filed 15 May 2018.